PARSIPPANY, NJ, May 19, 2010 (MARKETWIRE via COMTEX) --The Medicines Company (NASDAQ: MDCO) will present at the 2010 Citi
Global Health Care Conference on Wednesday , May 26th, in New York,
beginning at 11am Eastern Time. Clive Meanwell, Chairman and Chief
Executive Officer, will provide a company overview and outlook in the
presentation.
The session will be webcast with a link available at The Medicines
Company's website http://www.themedicinescompany.com under "Events."
About The Medicines Company
The Medicines Company (NASDAQ: MDCO) is
focused on advancing the treatment of critical care patients through
the delivery of innovative, cost-effective medicines to the worldwide
hospital marketplace. The Company markets Angiomax(R) (bivalirudin)
in the United States and other countries for use in patients
undergoing coronary angioplasty, and Cleviprex(R) (clevidipine
butyrate) injectable emulsion in the United States for the reduction
of blood pressure when oral therapy is not feasible or not desirable.
The Medicines Company's website is www.themedicinescompany.com.
Contact:
Michael Mitchell
The Medicines Company
973-290-6000
investor.relations@themedco.com
SOURCE: The Medicines Company
mailto:investor.relations@themedco.com
